Abstract
Introduction
Faced with a dramatic slowdown in sales in mature pharmaceutical markets,
multinational pharmaceutical companies are looking to substantially increase
their sales in India and other emerging markets. The Indian market is growing
by more than 10% per year, but foreign companies will need to overcome signifi
cant obstacles to succeed in a market currently dominated by domestic
manufacturers.
Questions Answered in This Report
- The Indian population is forecast to grow from its present size of 1.2
billion to 1.7 billion in 2050. How will the age breakdown of the
population evolve over time? How will the balance between India' s urban and
rural populations change in the coming years?
- Only a minority of Indians have health insurance. What are the main
forms of health insurance? How do most Indians fund healthcare and
medications?
- The Indian government controls the prices of 74 scheduled medicines.
Which agents are subject to price control? How are prices of other drugs
regulated? How does the government penalize overcharging for drugs? How do
prices in India compare with prices in other markets? What pricing reforms is
the Indian government contemplating?
Scope
- Demographic trends: population breakdown by age and sex; population
breakdown by geographic distribution.
- Organization and funding of healthcare: overview of the Indian
healthcare system; access to healthcare; health insurance; out-of-pocket
expenditures.
- Pharmaceutical pricing: historical price controls; current price
control system; price adjustments; penalties for overcharging for drugs;
international price comparison; multinational companies' pricing strategies.
- Outlook and implications for the pharmaceutical industry:
encouraging commercial outlook; potential government reforms;
opportunities and threats for multinationals.
| 
View Cart
